2) In nude mice with tumors, Levosimendan not only down-regulated Pfkfb3 to reduce renal damage but also suppressed PD-L1, enhancing the efficacy of CDDP chemotherapy, which resulted in a reduction in tumor size (Fig.9&S2). The gene discussed is PFKFB3; the disease is neoplasm.